Logullo Angela F, Prigenzi Karla C K, Nimir Cristiane C B A, Franco Andreia F V, Campos Mario S D A
Department of Pathology, Paulista School of Medicine, Federal University of São Paulo (UNIFESP), São Paulo 04023-062, Brazil.
Department of Pathology, Femme Laboratories, São Paulo 04004-030, Brazil.
Mol Clin Oncol. 2022 Apr;16(4):81. doi: 10.3892/mco.2022.2514. Epub 2022 Feb 10.
Mammary microcalcifications (MCs) are calcium deposits that are considered as robust markers of breast cancer when identified on mammography. MCs are frequently associated with premalignant and malignant lesions. The aim of the present review was to describe the MC types and associated radiological and pathological aspects in detail, provide insights and approaches to the topic, and describe specific clinical scenarios. The primary MC types are composed of calcium oxalate, hydroxyapatite and hydroxyapatite associated with magnesium. The first type is usually associated with benign conditions, while the others remain primarily associated with malignancy. Radiologically, MCs are classified as benign or suspicious. MCs may represent an active pathological mineralization process rather than a passive process, such as degeneration or necrosis. Practical management of breast specimens requires finely calibrated radiological pathological procedures. Understanding the molecular and structural development of MCs may contribute to breast lesion detection and treatment.
乳腺微钙化(MCs)是钙沉积物,在乳腺钼靶检查中被发现时,被视为乳腺癌的有力标志物。MCs常与癌前病变和恶性病变相关。本综述的目的是详细描述MC的类型以及相关的放射学和病理学方面,提供对该主题的见解和方法,并描述特定的临床情况。主要的MC类型由草酸钙、羟基磷灰石以及与镁相关的羟基磷灰石组成。第一种类型通常与良性情况相关,而其他类型主要仍与恶性肿瘤相关。在放射学上,MCs被分类为良性或可疑。MCs可能代表一个活跃的病理性矿化过程,而不是一个被动过程,如退变或坏死。乳腺标本的实际处理需要精细校准的放射病理程序。了解MCs的分子和结构发展可能有助于乳腺病变的检测和治疗。